Utah Medical Products, Inc.
UTMD
$58.33
-$0.33-0.56%
| Weiss Ratings | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | C | |||
| Rating Factors | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Fair | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.76 | |||
| Price History | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.72% | |||
| 30-Day Total Return | -7.16% | |||
| 60-Day Total Return | -8.05% | |||
| 90-Day Total Return | -9.62% | |||
| Year to Date Total Return | -4.92% | |||
| 1-Year Total Return | -14.31% | |||
| 2-Year Total Return | -35.45% | |||
| 3-Year Total Return | -30.27% | |||
| 5-Year Total Return | -26.15% | |||
| 52-Week High % Change | -24.14% | |||
| 52-Week Low % Change | 0.19% | |||
| Price | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $77.33 | |||
| 52-Week Low Price | $58.55 | |||
| 52-Week Low Price (Date) | Mar 05, 2025 | |||
| 52-Week High Price (Date) | Jul 24, 2024 | |||
| Valuation | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 198.95M | |||
| Enterprise Value | 116.26M | |||
| Price/Earnings (TTM) | 13.74 | |||
| Earnings Per Share (TTM) | 4.27 | |||
| Earnings Per Share Growth | -8.08% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.63 | |||
| Price/Book (Q) | 1.63 | |||
| Enterprise Value/Revenue (TTM) | 2.64 | |||
| Price | $58.33 | |||
| Enterprise Value/EBITDA (TTM) | 5.49 | |||
| Enterprise Value/EBIT | 6.43 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.48M | |||
| Dividend Yield | 2.05% | |||
| Div. Per Share (Most Recent) | $0.31 | |||
| Dividend Per Share (TTM) | $1.21 | |||
| Payout Ratio (TTM) | 28.14% | |||
| Dividend Per Share (Most Recent) | $0.31 | |||
| Company Info | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 801 566 1200 | |||
| Address | 7043 South 300 West Midvale, UT 84047-1048 | |||
| Website | www.utahmed.com | |||
| Country | United States | |||
| Year Founded | 1978 | |||
| Profitability | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 40.98% | |||
| Profit Margin | 34.61% | |||
| Management Effectiveness | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.65% | |||
| Return on Equity | 12.31% | |||
| Income Statement | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 44.08M | |||
| Total Revenue (TTM) | 44.08M | |||
| Revenue Per Share | $12.67 | |||
| Gross Profit (TTM) | 25.92M | |||
| EBITDA (TTM) | 21.17M | |||
| EBIT (TTM) | 18.07M | |||
| Net Income (TTM) | 15.26M | |||
| Net Income Avl. to Common (TTM) | 15.26M | |||
| Total Revenue Growth (Q YOY) | -19.99% | |||
| Earnings Growth (Q YOY) | -9.45% | |||
| EPS Diluted (TTM) | 4.27 | |||
| EPS Diluted Growth (Q YOY) | -5.56% | |||
| Balance Sheet | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 88.45M | |||
| Cash Per Share (Q) | $25.43 | |||
| Total Current Assets (Q) | 101.66M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 124.20M | |||
| Current Ratio (Q) | 29.594 | |||
| Book Value Per Share (Q) | $36.10 | |||
| Total Assets (Q) | 129.69M | |||
| Total Current Liabilities (Q) | 3.44M | |||
| Total Debt (Q) | 299.00K | |||
| Total Liabilities (Q) | 5.50M | |||
| Total Common Equity (Q) | 124.20M | |||
| Cash Flow | UTMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -289.00K | |||
| Cash from Financing (TTM) | -17.16M | |||
| Net Change in Cash (TTM) | 243.00K | |||
| Levered Free Cash Flow (TTM) | 14.08M | |||
| Cash from Operations (TTM) | 17.23M | |||
